These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10845734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C, Mosier M, Penry K.
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [Abstract] [Full Text] [Related]

  • 7. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
    Appleton RE, Peters AC, Mumford JP, Shaw DE.
    Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G, Yang H, Williams B, Zhou S, Laurenza A, Fain R.
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vigabatrin withdrawal randomized study in children.
    Chiron C, Dulac O, Gram L.
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [Abstract] [Full Text] [Related]

  • 16. Vigabatrin: 2008 update.
    Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vigabatrin versus carbamazepine monotherapy for epilepsy.
    Xiao Y, Gan L, Wang J, Luo M, Luo H.
    Cochrane Database Syst Rev; 2012 Jan 18; 1():CD008781. PubMed ID: 22258989
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group.
    Mauguière F, Chauvel P, Dewailly J, Dousse N.
    Epilepsia; 1997 Mar 18; 38(3):301-8. PubMed ID: 9070592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.